Nivolumab for High-Risk MDS/AML Patients After Allogeneic Stem Cell Transplant With Post-Transplant Cyclophosphamide

Clinical trial NCT04361058 · WITHDRAWN

Trial details

NCT number: NCT04361058
Sponsor: SCRI Development Innovations, LLC
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Leukemia, Myeloid, Acute Myelodysplastic Syndromes Myelodysplastic Syndrome Acute Myeloid Leukemia

Start date: 2020-04-13
Primary completion: 2021-04-20
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.